Reorganizing the Global Pharmacovigilance Function

Summer Foote

An F200 pharma company was reevaluating the operating model of its global drug safety and pharmacovigilance functions. Looking for help assessing cost, quality, and productivity impact of different resourcing scenarios, the group’s head turned to BTG. We delivered an independent pharmacovigilance organization specialist and former engagement lead in Accenture’s life science practice. She worked with internal executives to evaluate the most efficient model, then develop detailed organization-wide communication and implementation plans.

Previous Flipbook
Biopharma in the Time of COVID-19
Biopharma in the Time of COVID-19

Get on-demand talent to help you fuel your critical initiatives, pivot faster, and cover any skills or capa...

Next Article
Why Work With Independent Clinical Operations Consultants?
Why Work With Independent Clinical Operations Consultants?

Speed is key in life science product development. Delays cost, as do mistakes. With independent clinical op...

Find the perfect life science consultant.

Start a Project